Compare Credo Technology Group Holding Ltd (CRDO) vs Cronos Group Inc (CRON) Price & Performance

CRDO trades at $211.86, down 3.7% today, but maintains strong bullish technical momentum with support at $204 and resistance at $222. The company demonstrates exceptional fundamental strength with 114.7% year-over-year revenue growth and 33.83% net income margin, though valuation metrics remain elevated with a P/E of 74.6. Recent earnings beats and analyst optimism highlight CRDO's position as a key AI infrastructure play.

Outlook remains positive with 87.5% analyst buy ratings and $267.33 consensus price target representing 26% upside. Key opportunities include AI-driven data center expansion and optical technology growth, while risks center on premium valuation, customer concentration, and execution challenges in maintaining triple-digit growth rates.

CRON trades at $3.22, down 0.62% on the day, amid a bearish technical signal. The stock shows mixed earnings history, with recent beats in Q1 and Q2 2026 but a miss in Q4 2025. Revenue growth is robust, increasing from $118M in 2024 to $147M in 2025, with a projected rise to $179M in 2026. However, profitability remains volatile, with a net loss of $9.45M in 2025 despite a strong gross margin of 45.86%. Recent news highlights the company's Investor Day focusing on global expansion and cash flow generation.

The outlook for CRON is cautiously optimistic, driven by international growth and a debt-free balance sheet with $827M in cash. Key risks include ongoing profitability challenges, competitive pressures, and regulatory uncertainties in the cannabis sector. Analyst sentiment is mixed, with 60% hold ratings, suggesting a wait-and-see approach. Investors should weigh strong revenue trends against execution risks and margin volatility.